Journal of Osteoporosis and Physical Activity
Open Access

Understanding Osteoporosis: Causes, Risks, Prevention, and Effective Treatment Options

Ronit Kulkarni^{* *}Correspondence: Ronit Kulkarni, Department of Orthopaedics and Physical Medicine, Jonathan Lucas Street, Charleston, United States, Email:

Author info »

Description

Osteoporosis is a chronic condition characterized by reduced bone mass and deterioration of bone tissue, leading to increased bone fragility and susceptibility to fractures. Often referred to as the “silent disease,” osteoporosis typically progresses without symptoms until a fracture occurs. This disease affects millions worldwide, predominantly postmenopausal women, but men and younger individuals are also at risk. As populations age, understanding osteoporosis, its risk factors, prevention, and treatment becomes increasingly important [1].

The human skeleton is constantly remodeling itself. In childhood and early adulthood, bone formation outpaces bone resorption, allowing for growth and strengthening of the skeleton. However, as people age—particularly after their 30s—this balance shifts. Bone resorption gradually begins to exceed bone formation, leading to a decrease in bone density. In some individuals, this process accelerates, resulting in osteoporosis. The bones most commonly affected include the spine, hips, and wrists, and fractures in these areas can lead to significant disability and decreased quality of life [2].

Several risk factors contribute to the development of osteoporosis. The most significant non-modifiable risk factor is age. Bone density naturally declines as part of the aging process. Gender also plays a crucial role, with women being at a higher risk due to the rapid decline in estrogen levels during menopause. Genetics is another important factor—individuals with a family history of osteoporosis or fractures are more likely to develop the disease themselves. Ethnicity may also influence risk; for example, Caucasian and Asian populations are more prone to osteoporosis compared to other ethnic groups [3].

Lifestyle and environmental factors also have a substantial impact. Poor dietary habits, particularly a lack of calcium and vitamin D, significantly contribute to weak bones. Calcium is essential for maintaining bone strength, while vitamin D enhances calcium absorption. Physical inactivity, especially a sedentary lifestyle without weight-bearing exercises, can lead to bone loss. Additionally, smoking and excessive alcohol consumption negatively affect bone health. Certain medications, such as corticosteroids, anticonvulsants, and some cancer treatments, may also lead to decreased bone density over time [4].

Diagnosing osteoporosis is generally achieved through Bone Mineral Density (BMD) testing using Dual-Energy X-ray Absorptiometry (DEXA or DXA). This scan measures bone density, usually in the spine and hip, and compares the results to a reference population. A T-score of -2.5 or lower is indicative of osteoporosis. Those with lower scores are at a greater risk of fractures. Screening is often recommended for postmenopausal women over the age of 65 and men over the age of 70, or earlier if risk factors are present [5].

Preventing osteoporosis involves a combination of lifestyle changes and, in some cases, medication. Adequate intake of calcium and vitamin D is vital. Dairy products, leafy green vegetables, fortified foods, and supplements are good sources of calcium. Vitamin D can be obtained from sunlight exposure, fatty fish, and supplements. Regular exercise, particularly weight-bearing and resistance activities like walking, jogging, or lifting weights, helps maintain bone strength. Avoiding tobacco and limiting alcohol consumption also significantly reduce risk [6].

For individuals already diagnosed with osteoporosis or those at high risk, medical treatment may be necessary. The most commonly prescribed medications include bisphosphonates, which help slow bone loss and reduce fracture risk. Other medications such as Selective Estrogen Receptor Modulators (SERMs), Hormone Replacement Therapy (HRT), denosumab, and newer agents like romosozumab may be considered depending on the individual’s specific risk profile and tolerance. These treatments aim not only to preserve bone density but also to reduce the likelihood of fractures [7].

Fractures caused by osteoporosis, especially hip and vertebral fractures, can have serious consequences. Hip fractures often require surgery and lengthy rehabilitation and are associated with a higher risk of mortality, especially in the elderly. Vertebral fractures can cause chronic pain, loss of height, and spinal deformity. These complications highlight the importance of early diagnosis, prevention, and appropriate treatment [8].

Beyond physical health, osteoporosis can significantly impact mental and emotional well-being. The fear of falling or breaking a bone can lead to reduced activity, social isolation, and even depression. Comprehensive care often includes fall prevention strategies, home safety assessments, and support for mental health [9].

Research into osteoporosis continues to advance. Scientists are exploring genetic markers that could predict an individual’s risk, developing new drugs that target the biological pathways involved in bone remodeling, and improving diagnostic tools. Public health campaigns aim to raise awareness, especially among aging populations, to promote early detection and lifestyle changes that can mitigate risk [10].

Conclusion

Osteoporosis is a widespread yet preventable and treatable disease. While it predominantly affects older adults, risk factors can accumulate much earlier in life, making early intervention essential. Through a combination of proper nutrition, regular exercise, lifestyle modifications, and medical management when necessary, individuals can significantly reduce their risk of osteoporosis and related fractures. As our understanding of bone health grows, so too does our ability to protect and enhance the quality of life for those affected by this silent but serious condition.

References

1. Bu J, Xu X, Luo Y, Liu J, Zhou F. SENP3 alleviates osteoporosis via promoting SIRT3 transcription through the increase of DLX2 stability via SUMO2/3. Cell Biol Toxicol. 2025;41(1):99.

   [Crossref] [Google Scholar] [Pubmed]

2. Alnasser SM, Babakair RA, Al Mukhlid AF, Al Hassan SS, Nuhmani S, Muaidi Q, et al. Effectiveness of Exercise Loading on Bone Mineral Density and Quality of Life Among People Diagnosed with Osteoporosis, Osteopenia, and at Risk of Osteoporosis-A Systematic Review and Meta-Analysis. J Clin Med. 2025;14(12):4109.

   [Crossref] [Google Scholar] [Pubmed]

3. Zeng X, Su Y, Tan A, Zou L, Zha W, Yi S, et al. The association of coffee consumption with the risk of osteoporosis and fractures: A systematic review and meta-analysis. Osteoporos Int. 2022;33(9):1871-1893.

   [Crossref] [Google Scholar] [PubMed]

4. Chen S, Chen T, Chen Y, Huang D, Pan Y. Causal association between tea consumption and bone health: A mendelian randomization study. Front Nutr. 2022;9:872451.

   [Crossref] [Google Scholar] [PubMed]

5. Perez-Gomez J, Olmedillas H, Delgado-Guerra S, Royo IA, Vicente-Rodriguez G, Ortiz RA, et al. Effects of weight lifting training combined with plyometric exercises on physical fitness, body composition, and knee extension velocity during kicking in football. Appl Physiol Nutr Metab. 2008;33(3):501-510.

   [Crossref] [Google Scholar] [PubMed]

6. Mirza R, El Rabbany M, Ali DS, Tetradis S, Morrison A, Ruggiero S, et al. Dental implant failure and medication-related osteonecrosis of the jaw (MRONJ) related to dental implants in patients taking antiresorptive therapy for osteoporosis: a systematic review and meta-analysis. Endocr Pract. 2025: S1530-891X(25)00916-4.

   [Crossref] [Google Scholar] [Pubmed]

7. Stone MH, Pierce KC, Sands WA, Stone ME. Weightlifting: A brief overview. Strength Cond J. 2006;28(1):50-66.

   [Google Scholar]

8. Kim JE, Hsieh MH, Soni BK, Zayzafoon M, Allison DB. Childhood obesity as a risk factor for bone fracture: a mechanistic study. Obesity. 2013;21(7):1459-1466.

   [CrossRef] [Google Scholar] [PubMed]

9. Drake MT, Clarke BL, Lewiecki EM. The pathophysiology and treatment of osteoporosis. Clin Ther. 2015;37: 1837–1850.

   [CrossRef] [Google Scholar] [PubMed]

10. Li M, Nichol P, Lee L, Levin RM. Estrogen modulates permeability and prostaglandin levels in the rabbit urinary bladder. Prostaglandins Leukot Essent Fatty Acids. 2009;80: 125-129.

    [CrossRef] [Google Scholar] [PubMed]